Savara SVRA
NASDAQ SVRA
$4.84 -0.21 (-4.16%)
As of: Oct 2, 2026 · 1:39 PM EDT

Savara (SVRA) Short-Term Debt repayments (2016 - 2017)

Updated

Savara (SVRA) posted Short-Term Debt repayments of $368,000 for Q1 2017, down 96.4% from the prior quarter.

Analysis

Savara (SVRA) Short-Term Debt repayments (2016 - 2017) Analysis & Trends

For FY2016, Savara's Short-Term Debt repayments came in at $11.65 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.45 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Savara 1.06 Bn 1.06 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 368,000.00
Dec 31, 2016 10.36 Mn
API Access

Savara Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=SVRA&period=max&api_key=YOUR_API_KEY